source
- Proposed Biotech Investment National Security Act may protect US firms but contains loophole aiding Chinese competitionA bipartisan bill called the Biotech Investment National Security Act (BINSA) has been introduced in Congress to expand federal oversight of biotechnology activities, from drug development to biolo…
- Akeso CEO says biliary tract cancer data could be a breakthroughAkeso’s chief executive Michelle Xia told ChinaPharma that the company’s PD-1xVEGF bispecific antibody, ivonescimab, is generating strong interest after early biliary tract cancer results. She not…